PRTG

Portage Biotech Inc.

0.79 USD
+0.18 (+29.57%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Portage Biotech Inc. stock is down -9.15% since 30 days ago. The next earnings date is Jul 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 34.48% of the previous 28 March’s closed higher than February.

About Portage Biotech Inc.

Portage Biotech Inc. researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology.